The FDA approved a first drug–device product that uses a digital chip to monitor ingestion. This tracking technology could help address the costly problem of poor drug adherence in both medical practice and clinical trials, if it lives up to its promise…

Para acessar a publicação na íntegra clique aqui

Fonte: 818 | DECEMBER 2017 | VOLUME 16